Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.
Press releases published on July 31, 2025
ICPO and SBMN deepen their collaboration to advance Clinical Theranostics Centers of Excellence in Brazil
GlobeNewswire
·
July 31, 2025
ICPO accreditation following international theranostics guidelines and ICPO Academy for Theranostics will fuel the partnership right from start. July 31, 2025 – Wiesbaden, Germany, and Sao Paulo, Brazil. During the annual congress of the Society of Nuclear …
AMA: PBM Markets are at Risk of Harming Patients
GlobeNewswire
·
July 31, 2025
CHICAGO, July 31, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) today published a new annual analysis measuring competition in pharmacy benefit manager (PBM) markets and vertical integration of insurers with PBMs. The assessment …
Integra LifeSciences Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Second Quarter 2025 …
PL BioScience Announces Major Site Expansion
GlobeNewswire
·
July 31, 2025
New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production Site provides the world’s largest HPL output with 20,000L annual capacity and a dual-source GMP strategy for secure, resilient supply …
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025
GlobeNewswire
·
July 31, 2025
(OXFORDSHIRE, England …
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range
GlobeNewswire
·
July 31, 2025
Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range Paris, July 31, 2025 Q2 sales growth of 10.1% at CER1 and business EPS2 of €1.59 Pharma launches increased sales by 39.8%, …
Communiqué de presse : T2 : croissance à deux chiffres desventes, nette progression du BNPA des activités ; perspectives de ventes 2025 revues à la hausse avec une croissance désormais attendue dans le haut de la fourchette à un chiffre
GlobeNewswire
·
July 31, 2025
T2 : croissance à deux chiffres des ventes, nette progression du BNPA des activités ; perspectives de ventes 2025 revues à la hausse avec une croissance désormais attendue dans le haut de la fourchette à un chiffre Paris, le 31 juillet 2025 Ventes du T2 en …
Pharming Group reports second quarter and first half 2025 financial results and provides business update
GlobeNewswire
·
July 31, 2025
Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growth RUCONEST® second quarter revenue increased by 28% to US$80.4 million, compared to the second …
argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update
GlobeNewswire
·
July 31, 2025
$949 million in second quarter global product net sales VYVGART SC launch in CIDP progresses with more than 2,500 patients on treatment globally ARGX-119 to advance to registrational study in CMS following positive proof of concept data; three additional …
Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
GlobeNewswire
·
July 31, 2025
H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in Oncology H1 core operating income of €656m, growing by 21.9% as reported, with a core operating …
Ipsen publie de solides résultats au premier semestre 2025 et relève ses objectifs financiers annuels
GlobeNewswire
·
July 31, 2025
Croissance des ventes totales du Groupe de 11,4% à taux de change constant1 ou 9,7% en données publiées, tirée par les trois aires thérapeutiques : 95,7% dans les Maladies Rares, 9,7% en Neurosciences et 6,4% en Oncologie Résultat opérationnel des …
Prime Medicine Announces Pricing of Public Offering
GlobeNewswire
·
July 31, 2025
CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten …
Revive Therapeutics Announces Proposed Private Placement and Debt Settlement
GlobeNewswire
·
July 31, 2025
TORONTO, July 30, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …